Short CV/Education and training

  • 1984
    Diplom degree in biochemistry, Martin Luther University Halle-Wittenberg, Germany

  • 1991
    Expert scientist in biochemistry in medicine

  • 1991
    Doctor of Natural Science (Dr. rer. nat.), Humboldt University, Berlin, Germany

  • 1991 – 1993
    Postdoc, Max Delbrück Centre for Molecular Medicine (MDC), Berlin

  • 1994 – 1995
    Postdoc, National Cancer Institute, Frederick, MD, USA

  • 1996 – 2000
    Team leader (research unit surgical oncology), Max Delbrück Centre for Molecular Medicine (MDC), Berlin

  • 2001 – 2006
    Team leader (research unit surgical oncology), Robert Rössle Clinic, Charité, Berlin

  • 2003
    Habilitation (postdoctoral qualification), Charité Universitätsmedizin, Berlin

  • Since 2007
    Team leader (research unit surgical oncology), Experimental and Clinical Research Centre, Charité, Berlin

  • 2009
    Professor, Charité Universitätsmedizin, Berlin

  • Alumni visiting researcher at the National Cancer Institute, Frederick, MD, USA, 1996, 1997, 1998, 2001, 2003, 2007, 2011

Selected publications

  • Stein, U, Arlt, F, Walther, W, Smith, J, Waldman, T, Harris, ED, Mertins, SD, Heizmann, CW, Allard, D, Birchmeier, W, Schlag, PM, & Shoemaker RH. (2006) The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology, 131,1486-1500.

  • Stein, U, Walther, W, Arlt, F, Schwabe, H, Smith, J, Fichtner, I, Birchmeier, W, & Schlag, PM. (2009) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med, 15,59-67.

  • Stein, U, Smith, J, Walther, W, & Arlt, F. (2009) MACC1 controls Met ? what a difference an Sp1 site makes. Cell Cycle, 8,2467-2469.

  • Stein, U, Dahlmann, M, & Walther, W. (2010) MACC1 ? more than metastasis? Facts and predictions about a novel gene. J Mol Med, 88,11-18.

  • Sack, U, Walther, W, Scudiero, D, Selby, M, Aumann, J, Lemos, C, Fichtner, I, Schlag, PM, Shoemaker, RH, & Stein U. (2011) S100A4-induced cell motility and metastasis is restricted by the Wnt/?-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell, 22,3344-3354.

  • Stein, U, Arlt, F, Smith, J, Sack, U, Herrmann, P, Walther, W, Lemm, M, Fichtner, I, Shoemaker, RH, & Schlag PM. (2011) Intervening in ?-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Neoplasia, 13,131-144.

  • Sack, U, Walther, W, Scudiero, D, Selby, M, Kobelt, D, Lemm, M, Fichtner, I, & Schlag PM, Shoemaker RH, & Stein U. (2011) Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst, 103,1018-1036.

  • Pichorner, A, Sack, U, Kobelt, D, Kelch, I, Arlt, F, Smith, J, Walther, W, Schlag, PM, & Stein U. (2012) In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice. Clin Exp Metastasis, 29,573-583.

  • Dahlmann, M, Sack, U, Herrmann, P, Lemm, M, Fichtner, I, Schlag, PM, & Stein U. (2012) Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation. Oncotarget, 3,783-797.

  • Schmid, F, Burock, S, Klockmeier, K, Schlag, PM, & Stein, U. (2012) SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer. Mol Cancer, 11:49. [Epub ahead of print]



Complete list of publications

Selected projects

  • MACC1: a newly identified gene regulates HGF/Met signalling, is a strong biomarker for prediction of colorectal cancer metastasis, and a promising target for metastasis inhibition

  • S100A4: Inhibition of colorectal cancer metastasis by Wnt/beta-catenin-pathway-oriented small molecules targeting the metastasis progressor S100A4

Membership in scientific bodies/juries

Bodies/Consortia:

  • German Consortium for Translational Cancer Research

  • Berlin School of Integrative Oncology

  • International PhD Program, Helmholtz Graduate School Molecular Cell Biology

  • Masters program Molecular Medicine, Charité Universitätsmedizin, Berlin

Specialist associations:

  • American Association for Cancer Research

  • European Association for Cancer Research

  • Deutsche Krebsgesellschaft (German cancer society), working group Experimental Cancer Research

  • Berliner Krebsgesellschaft (Berlin cancer society)

Contact

You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here

Testimonials

  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Prof. Dr. Seema Agarwal

    Physical sciencesPreparative and physical chemistry of polymersNanotechnology

  2. Dr. Chantal Abergel

    Biological and related sciences , Physical sciencesEnvironmental virology, Molecular and structural biology, biochemistry

  3. Dr. Ana Akrap

    Physical sciencesExperimental condensed matter physics

  4. Dr. Iris Altpeter

    Engineering and engineering trades , Physical sciencesMicromagnetic testing methods